Exon-skipping antisense oligonucleotides for cystic fibrosis therapy

Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene cause cystic fibrosis (CF), and the CFTR-W1282X nonsense mutation causes a severe form of CF. Although Trikafta and other CFTR-modulation therapies benefit most CF patients, targeted therapy for patients with the W1282X...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Young Jin, Sivetz, Nicole, Layne, Jessica, Voss, Dillon M., Yang, Lucia, Zhang, Qian, Krainer, Adrian R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784140/
https://www.ncbi.nlm.nih.gov/pubmed/35017301
http://dx.doi.org/10.1073/pnas.2114858118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784140/
https://www.ncbi.nlm.nih.gov/pubmed/35017301
http://dx.doi.org/10.1073/pnas.2114858118

Ejemplares similares